- Home
- HWC vs CRNX Comparison
HWC vs CRNX Comparison
Compare HWC & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWC
- CRNX
- Stock Information
- Founded
- HWC 1883
- CRNX 2008
- Country
- HWC United States
- CRNX United States
- Employees
- HWC N/A
- CRNX N/A
- Industry
- HWC Major Banks
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- HWC Finance
- CRNX Health Care
- Exchange
- HWC Nasdaq
- CRNX Nasdaq
- Market Cap
- HWC 5.2B
- CRNX 5.2B
- IPO Year
- HWC N/A
- CRNX 2018
- Fundamental
- Price
- HWC $60.74
- CRNX $38.76
- Analyst Decision
- HWC Buy
- CRNX Strong Buy
- Analyst Count
- HWC 9
- CRNX 10
- Target Price
- HWC $59.22
- CRNX $74.40
- AVG Volume (30 Days)
- HWC 618.5K
- CRNX 987.7K
- Earning Date
- HWC 01-21-2025
- CRNX 02-26-2025
- Dividend Yield
- HWC 2.65%
- CRNX N/A
- EPS Growth
- HWC N/A
- CRNX N/A
- EPS
- HWC 4.46
- CRNX N/A
- Revenue
- HWC $1,326,301,000.00
- CRNX $1,038,999.00
- Revenue This Year
- HWC N/A
- CRNX N/A
- Revenue Next Year
- HWC $2.32
- CRNX $196.17
- P/E Ratio
- HWC $13.61
- CRNX N/A
- Revenue Growth
- HWC N/A
- CRNX N/A
- 52 Week Low
- HWC $41.19
- CRNX $35.51
- 52 Week High
- HWC $62.40
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- HWC 65.95
- CRNX 29.69
- Support Level
- HWC $58.05
- CRNX $35.51
- Resistance Level
- HWC $60.08
- CRNX $53.55
- Average True Range (ATR)
- HWC 1.47
- CRNX 2.33
- MACD
- HWC 0.65
- CRNX -1.08
- Stochastic Oscillator
- HWC 99.73
- CRNX 18.02
About HWC Hancock Whitney Corporation
Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations and individuals and provides its customers access to investment advisory and brokerage products.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.